Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Generex Biotechnology Corp GNBT
(Total Views: 396)
Posted On: 12/16/2019 11:58:49 PM
Post# of 36566
Posted By: Paul Jackson
Re: Buildit #10117
To expound on Buildit's inventory idea - the inventory balance on 10Q is $727,263...and if we used the 19% as % of cost of goods sold, that means sales would be $3,827,700 ($727,263 divided by 19%)….let's just assume inventory is good for 3 months, revenue for the next 10Q maybe close $4 million...this is just pure math working the inventory number backwards...no idea on what the company will actually be pulling in.









Buildit wrote -

1) Finished Goods was built up by 130% or $367k. Hopefully this is largely Excellagen, and they are selling somewhat significant quantities now (relative to the paltry amount apparently sold in this Q).

Does anyone happen to know what the FG accounting method is? If it's a fairly std cost valuation, and it's primarily Excellagen as I hope, this could represent ~$15MM in potential revs. As Excellagen has a shelf life (can't remember, 3 months?), maybe this bodes well for the next Q. Anyone have any knowledge to add to this line of thinking?

Read More: https://investorshangout.com/post/newpost/622...z68Kw7Ko13













(1)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site